03/26/2013 - 7:55am

The National Community Pharmacists Association called for the rejection of a proposal made by Sens. Joe Manchin, D-W.Va., and Mark Kirk, R.-Ill., to reschedule Vicodin and other hydrocodone-containing products from Schedule III to Schedule II of the Controlled Substances Act.

03/25/2013 - 4:25pm

Kentucky became the first state to enact legislation that provides pharmacists with transparency into how health plans determine pharmacy reimbursements for generic drugs, and establishes an appeals process when a dispute arises over those payment levels.

03/25/2013 - 4:14pm

The Supreme Court heard arguments Monday in a case that could determine the future of generic drugs in America.

03/25/2013 - 12:41pm

The percentage of people who are at risk of developing Type 2 diabetes and aware of it has risen slightly over the past few years, but remains low, according to a report by the Centers for Disease Control and Prevention.

03/25/2013 - 12:00pm

The Food and Drug Administration has approved a treatment for managing a type of bacterial infection in patients with cystic fibrosis.

03/25/2013 - 11:33am

Generic drug maker Actavis has reached a deal with AstraZeneca that will allow it to launch a version of a drug used to treat cholesterol in three years, Actavis said Monday.

03/25/2013 - 10:51am

More than 400 drugs are under development for the 10 most common chronic health conditions affecting elderly people, according to a new report by a drug industry trade group.

03/25/2013 - 10:14am

Boehringer Ingelheim and Eli Lilly are seeking regulatory approval for an experimental drug to treat Type 2 diabetes, the companies said.

03/25/2013 - 9:35am

LifeScan initiated a voluntary recall and replacement for all of its OneTouch VerioIQ blood-glucose meters in the United States, effective immediately.